TW278079B - - Google Patents

Info

Publication number
TW278079B
TW278079B TW083102182A TW83102182A TW278079B TW 278079 B TW278079 B TW 278079B TW 083102182 A TW083102182 A TW 083102182A TW 83102182 A TW83102182 A TW 83102182A TW 278079 B TW278079 B TW 278079B
Authority
TW
Taiwan
Application number
TW083102182A
Original Assignee
Caroma Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caroma Ind Ltd filed Critical Caroma Ind Ltd
Application granted granted Critical
Publication of TW278079B publication Critical patent/TW278079B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
TW083102182A 1993-03-31 1994-03-14 TW278079B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner

Publications (1)

Publication Number Publication Date
TW278079B true TW278079B (zh) 1996-06-11

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102182A TW278079B (zh) 1993-03-31 1994-03-14

Country Status (16)

Country Link
US (1) US5700914A (zh)
EP (1) EP0691984A1 (zh)
JP (1) JPH08508264A (zh)
CN (1) CN1039231C (zh)
AU (1) AU677309B2 (zh)
CA (1) CA2159313A1 (zh)
CZ (1) CZ253395A3 (zh)
DK (1) DK38293D0 (zh)
FI (1) FI954649A (zh)
HU (1) HUT72712A (zh)
IL (1) IL109164A0 (zh)
NO (1) NO953883L (zh)
PL (1) PL310887A1 (zh)
TW (1) TW278079B (zh)
WO (1) WO1994022905A1 (zh)
ZA (1) ZA941956B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) * 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
PT1308455E (pt) † 1998-05-06 2006-08-31 Genentech Inc Composicao compreendendo anticorpos anti-her2
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
ATE428445T1 (de) 2000-02-11 2009-05-15 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
AU2002351756A1 (en) 2001-12-21 2003-07-15 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
EP2283856B1 (en) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabilised solid compositions of factor VIIa polypeptides
WO2004083421A1 (en) 2003-03-18 2004-09-30 Novo Nordisk Health Care Ag Method for the production of gla-residue containing serine proteases
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
MXPA05012476A (es) * 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
WO2004112828A1 (en) 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
DE602004023848D1 (de) * 2003-07-01 2009-12-10 Novo Nordisk Healthcare Ag Von factor vii polypeptiden
BRPI0413518A (pt) 2003-08-14 2006-10-10 Novo Nordisk Healthcare Ag composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético
WO2005054275A2 (en) 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor vii solutions to remove virus
TR201809670T4 (tr) * 2003-12-19 2018-07-23 Novo Nordisk Healthcare Ag Faktör VII polipeptitlerinin stabilize edilmiş kompozisyonları.
JP2008525381A (ja) * 2004-12-23 2008-07-17 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 関心のあるビタミンｋ依存性タンパク質を含んでなる組成物中におけるタンパク質混入物の量の減少
WO2006074664A1 (en) * 2005-01-14 2006-07-20 Maxygen Holdings Ltd. Method for purification of factor vii
DK1907540T3 (da) * 2005-07-22 2013-03-11 Bayer Healthcare Llc Aktivering af faktor VII i opløsning
US8334257B2 (en) * 2005-12-20 2012-12-18 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
EP3412300A1 (en) 2008-06-27 2018-12-12 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
RU2646502C2 (ru) 2012-10-17 2018-03-05 Дзе Проктер Энд Гэмбл Компани Полоска для доставки активного вещества для ухода за полостью рта и способы доставки активных веществ для ухода за полостью рта
WO2018117143A1 (ja) 2016-12-22 2018-06-28 一般財団法人化学及血清療法研究所 血液凝固第ｖｉｉ因子の高収率回収のためのクロマトグラフィー法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
US5700914A (en) 1997-12-23
WO1994022905A1 (en) 1994-10-13
ZA941956B (en) 1994-09-30
CN1039231C (zh) 1998-07-22
DK38293D0 (da) 1993-03-31
NO953883D0 (no) 1995-09-29
EP0691984A1 (en) 1996-01-17
NO953883L (no) 1995-11-28
AU6423994A (en) 1994-10-24
FI954649A0 (fi) 1995-09-29
PL310887A1 (en) 1996-01-08
IL109164A0 (en) 1994-06-24
CA2159313A1 (en) 1994-10-13
HUT72712A (en) 1996-05-28
JPH08508264A (ja) 1996-09-03
AU677309B2 (en) 1997-04-17
HU9502846D0 (en) 1995-12-28
FI954649A (fi) 1995-09-29
CZ253395A3 (en) 1996-01-17
CN1121723A (zh) 1996-05-01

Similar Documents

Publication Publication Date Title
FR10C0052I2 (zh)
FR2707878B1 (zh)
TW278079B (zh)
FR2713848B1 (zh)
FR2713489B1 (zh)
IN188216B (zh)
KR19960520000A (zh)
FR2706794B1 (zh)
FR2723263B1 (zh)
FR2710786B1 (zh)
FR2706786B1 (zh)
IN178265B (zh)
IN176669B (zh)
IN185944B (zh)
IN187173B (zh)
IN187343B (zh)
IN187395B (zh)
IN188026B (zh)
ECSDI930146S (zh)
ITFI960097V0 (zh)
ITRM960178V0 (zh)
ECSDI930173S (zh)
ECSDI930160S (zh)
ECSDI930159S (zh)
ECSDI930158S (zh)

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees